<code id='FA4069BA74'></code><style id='FA4069BA74'></style>
    • <acronym id='FA4069BA74'></acronym>
      <center id='FA4069BA74'><center id='FA4069BA74'><tfoot id='FA4069BA74'></tfoot></center><abbr id='FA4069BA74'><dir id='FA4069BA74'><tfoot id='FA4069BA74'></tfoot><noframes id='FA4069BA74'>

    • <optgroup id='FA4069BA74'><strike id='FA4069BA74'><sup id='FA4069BA74'></sup></strike><code id='FA4069BA74'></code></optgroup>
        1. <b id='FA4069BA74'><label id='FA4069BA74'><select id='FA4069BA74'><dt id='FA4069BA74'><span id='FA4069BA74'></span></dt></select></label></b><u id='FA4069BA74'></u>
          <i id='FA4069BA74'><strike id='FA4069BA74'><tt id='FA4069BA74'><pre id='FA4069BA74'></pre></tt></strike></i>

          knowledge

          knowledge

          author:fashion    Page View:352
          Pharmacy shelves
          A conservative group advocating against changing how pharmacy middlemen operate spent more than $1 million on lobbying last quarter. GEORGE FREY/AFP via Getty Images

          WASHINGTON — A conservative group advocating against changing how pharmacy middlemen operate spent more than $1 million on lobbying last quarter — its highest-ever spend by far, according to federal filings.

          The Council for Citizens Against Government Waste spent $1.1 million on lobbying last quarter, and only employed a single lobbyist. That’s 22 times the $50,000 it spent in the same quarter last year. Its prior spending record was $700,000, from the start of 2020.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          Biotech stock slump in 2023: awaiting the turnaround
          Biotech stock slump in 2023: awaiting the turnaround

          AdobeThiswassupposedtobetheyearofthebiotechcomeback,whenpromisingnewmedicinesandhigh-dollarbuyoutswo

          read more
          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more

          Biotech stock slump in 2023: awaiting the turnaround

          AdobeThiswassupposedtobetheyearofthebiotechcomeback,whenpromisingnewmedicinesandhigh-dollarbuyoutswo